Wolverine Trading, LLC Reata Pharmaceuticals Inc Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 11, 2020
SELL
$124.16 - $247.74 $1.05 Million - $2.1 Million
-8,485 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$74.57 - $217.92 $450,775 - $1.32 Million
6,045 Added 247.75%
8,485 $1.74 Million
Q3 2019

Nov 14, 2019
SELL
$71.26 - $95.75 $428,058 - $575,170
-6,007 Reduced 71.11%
2,440 $206,000
Q2 2019

Aug 20, 2019
BUY
$77.72 - $94.35 $145,647 - $176,811
1,874 Added 28.51%
8,447 $797,000
Q1 2019

May 15, 2019
BUY
$51.9 - $101.79 $341,138 - $669,065
6,573 New
6,573 $562,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email